
APOLIPOPROTEIN(a) POLYMORPHISMS IN A HEALTHY MACEDONIAN POPULATION Tosheska K*, Labudovic D, Alabakovska S, Todorova B *Corresponding Author: Katerina Tosheska K, MD, MSc., Department of Medical and Experimental Biochemistry, Faculty of Medicine, 50 Divizija 6, 1000 Skopje, Republic of Macedonia; Tel: +389-2-3217-303; Fax: +389-2-3230-431; E-mail: tosheskatrajkovska@yahoo.com
page: 49
|
ACKNOWLEDGMENTS
This study was supported by a grant from the USA-Macedonian Joint Fund for Scientific and Technological Corporation (Project No. 138/NIH).
 Figure 1. Frequency distribution of Lp(a) concentration
Figure 2. Correlation between Mr (kDa) of apo(a) isoforms and Lp(a) concentration
Table1. Frequency of apo(a) phenotypes in study subjects
Isoforms |
Men |
Women |
Total |
N |
% |
N |
% |
N |
% |
Single |
58 |
61.10 |
49 |
56.98 |
107 |
59.44 |
Double |
32 |
34.04 |
32 |
37.21 |
64 |
35.56 |
Null |
4 |
4.26 |
5 |
5.81 |
9 |
5 |
Total |
94 |
100.00 |
86 |
100.00 |
180 |
100.00 |
Table 2. Frequency of observed and expected phenotypes in the study population (N=180)
Isoforms |
Observed apo(a) isoforms |
Expected apo(a) isoforms |
Single |
N |
% |
N |
% |
>S4 |
14 |
12.07 |
11.767 |
10.27 |
S4 |
57 |
49.14 |
62.804 |
54.81 |
S3 |
32 |
27.59 |
24.810 |
21.65 |
S1 |
2 |
1.72 |
2.591 |
2.26 |
B |
2 |
1.72 |
2.050 |
1.79 |
Null |
9 |
7.76 |
10.565 |
9.22 |
Total |
116 |
100 |
114.587 |
100.00 |
Double |
|
|
|
|
>S4S4 |
22 |
34.38 |
15.683 |
23.93 |
>S4S3 |
1 |
1.56 |
7.959 |
12.14 |
>S4S1 |
0 |
0 |
1.112 |
1.70 |
S4S3 |
28 |
43.75 |
28.673 |
43.75 |
S4S1 |
6 |
9.38 |
4.005 |
6.11 |
>S4B |
0 |
0 |
0.889 |
1.36 |
S4B |
4 |
6.25 |
3.204 |
4.89 |
S3S1 |
1 |
1.56 |
2.032 |
3.10 |
S3B |
1 |
1.56 |
1.626 |
2.48 |
S1B |
1 |
1.56 |
0.352 |
0.54 |
Total |
64 |
100.00 |
65.535 |
100 |
Table 3. Molecular mass (kDa) of apo(a) isoforms and Lp(a) concentration in study subjects
Isoform |
Mr (kDa) (mean ± SD) |
Lp(a) mg/dL (mean ± SD) |
>S4 |
784.06 ± 16.87 |
9.68 ± 0.22 |
S4 |
714.04 ± 30.03 |
13.74 ± 11.40 |
S3 |
585.92 ± 20.25 |
16.55 ± 14.51 |
S1 |
520 ± 10 |
62.67 ± 8.93 |
B |
429.33 ± 18.01 |
52.97 ± 31.38 |
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|